Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,086 | -17,347 | -13,392 | -9,007 | -4,748 |
| Depreciation Amortization | 142 | 764 | 592 | 411 | 210 |
| Accounts payable and accrued liabilities | 388 | -110 | 49 | 39 | 41 |
| Other Working Capital | -516 | 461 | 646 | 109 | 101 |
| Other Operating Activity | 273 | 2,568 | 1,977 | 1,302 | 761 |
| Operating Cash Flow | $-4,799 | $-13,665 | $-10,129 | $-7,147 | $-3,635 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,000 | N/A | 0 | N/A | N/A |
| PPE Investments | N/A | -3 | -3 | -21 | -21 |
| Other Investing Activity | 6,327 | -6,527 | 0 | 0 | 0 |
| Investing Cash Flow | $4,327 | $-6,530 | $-3 | $-21 | $-21 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 35,068 | 5,283 | 4,859 | 4,859 |
| Other Financing Activity | -413 | 1,349 | 2,785 | -2,230 | -1,266 |
| Financing Cash Flow | $-413 | $36,417 | $8,068 | $2,629 | $3,592 |
| Beginning Cash Position | 30,841 | 14,618 | 14,618 | 14,618 | 14,618 |
| End Cash Position | 29,955 | 30,841 | 12,554 | 10,078 | 14,554 |
| Net Cash Flow | $-885 | $16,223 | $-2,064 | $-4,540 | $-64 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,799 | -13,665 | -10,129 | -7,147 | -3,635 |
| Capital Expenditure | 0 | -3 | -3 | -21 | -21 |
| Free Cash Flow | -4,799 | -13,667 | -10,131 | -7,169 | -3,656 |